TOVX Theriva Biologics: Prakiraan rega marang bathi

TOVX (Theriva Biologics, Inc.) - tandha merek perusahaan

How can risks be minimized in the development of anti-cancer viruses and microbiome protection? The projected P/E multiple for Theriva Biologics, Inc. (TOVX) reflects current market dynamics, where the current level is 0.00. The solution lies in synergy with scientific centers to create oncolytic drugs, which provides access to an unsaturated GI tumor therapy market with high deferred demand.

therivabio.com - Pangali mangsa ngarep rega marang bathi TOVX (periode 28.04.2023 - 18.11.2026)

Rincian metrik lan analitis perusahaan therivabio.com (TOVX)

Analisis fundamental perusahaan:Theriva Biologics Inc TOVX
Produk mawa merek Theriva Biologics, Inc.

Theriva Biologics, Inc. (TOVX) adherence to strict ESG standards and bioethics in immunotherapy builds long-term value, which investors must weigh against the market price via expected earnings. This ratio measures the premium paid for the asset, utilizing the company's forward P/E valuation to determine the extent to which current quotes are justified by future financial results and the risks of capital drawdown.

Analisis perusahaan pesaing

Pangali Forward P/E IBRX|Immunocore Holdings plc (IMCR) - Pangali forward rega marang bathi|Janux Therapeutics Inc - Prakiraan rega marang bathi|Arcus Biosciences (RCUS) - Rasio prakiraan rega marang bathi|ZYME: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TNGX (Tango Therapeutics, Inc.)|IOVA: Pangali Forward P/E|IMTX - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep xencor.com|Prakiraan rega marang bathi compasstherapeutics.com (CMPX)|Rega marang bathi mangsa ngarep Replimune Group Inc (REPL)|Prakiraan rega marang bathi Lyell Immunopharma Inc LYEL|Innate Pharma SA - Prakiraan rega marang bathi|Pangali Forward P/E Pyxis Oncology, Inc. PYXS|CGEN - Rega marang bathi mangsa ngarep|IOBT (iobiotech.com) - Rasio rega marang bathi mangsa ngarep|Sutro Biopharma, Inc (STRO) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi MiNK (INKT)|Prakiraan rega marang bathi HOWL|IMMX - Pangali forward rega marang bathi|Prakiraan rega marang bathi ALXO (ALX Oncology Holdings)|CUE (Cue Biopharma) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E PDSB (PDS Biotechnology)|Pangali mangsa ngarep rega marang bathi SONN|MAIABiotech.com - Pangali Forward P/E|Rasio prakiraan rega marang bathi Liminatus|Lava Tx (LVTX) - Rega marang bathi mangsa ngarep|NextCure, Inc. - Pangali mangsa ngarep rega marang bathi|LPTX (Leap Tx) - Pangali Forward P/E|Pangali Forward P/E intensitytherapeutics.com|Rega marang bathi mangsa ngarep senseibio.com (SNSE)|GRTS: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E KA (kinetabio.com)|neximmune.com (NEXI) - Rasio prakiraan rega marang bathi|TSBX: Prakiraan rega marang bathi|VCNX: Rega marang bathi mangsa ngarep|HARP: Pangali Forward P/E